Am J Epidemiol 2004; 159:750-758.
Copyright © 2004 by the Johns
Hopkins Bloomberg School of Public Health
ORIGINAL CONTRIBUTIONS |
Aggregation of Ovarian Cancer with Breast, Ovarian, Colorectal, and Prostate Cancer in First-degree Relatives
1 Cancer Etiology Program, Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI.
2 Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA.
Epidemiologic studies have demonstrated a tendency for common cancers to aggregate in families. The authors investigated the effects of family history of cancer at multiple sites, including the breast, ovary, colorectum, and prostate, on ovarian cancer risk among 607 controls and 558 ovarian cases in Hawaii and Los Angeles, California, in 1993–1999. A family history of cancer of the breast, ovary, colorectum, or prostate in first-degree relatives was associated with an increased risk of ovarian cancer (odds ratio (OR) = 1.7, 95% confidence interval (CI): 1.1, 2.6; OR = 3.2, 95% CI: 1.3, 7.9; OR = 1.5, 95% CI: 0.9, 2.5; and OR = 1.6, 95% CI: 1.0, 2.8, respectively). A greater risk of ovarian cancer was observed for women with parents rather than siblings with a history of breast or prostate cancer and for women with parental colorectal cancer diagnosed at an early age, suggesting a genetic predisposition among these women. The risk of nonmucinous tumors, but not mucinous tumors, was positively associated with a family history of cancer. No significant interaction effects on risk existed between oral contraceptive pill use or pregnancy and family history of breast and/or ovarian cancer. Study findings suggest that ovarian cancer aggregates with several common cancers in family members.
breast neoplasms; colorectal neoplasms; neoplastic syndromes, hereditary; ovarian neoplasms; prostatic neoplasms
Abbreviations: Abbreviations: CI, confidence interval; OR, odds ratio.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Pakkanen, E. Pukkala, H. Kainulainen, M. P. Matikainen, P. A. Koivisto, T. L.J. Tammela, and J. Schleutker Incidence of Cancer in Finnish Families with Clinically Aggressive and Nonaggressive Prostate Cancer Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 3049 - 3056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Ostrander and M. S. Udler The Role of the BRCA2 Gene in Susceptibility to Prostate Cancer Revisited Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1843 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lurie, L. R. Wilkens, P. J. Thompson, K. E. McDuffie, M. E. Carney, K. Y. Terada, and M. T. Goodman Vitamin D Receptor Gene Polymorphisms and Epithelial Ovarian Cancer Risk Cancer Epidemiol. Biomarkers Prev., December 1, 2007; 16(12): 2566 - 2571. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Agalliu, E. M. Kwon, D. Zadory, L. McIntosh, J. Thompson, J. L. Stanford, and E. A. Ostrander Germline Mutations in the BRCA2 Gene and Susceptibility to Hereditary Prostate Cancer Clin. Cancer Res., February 1, 2007; 13(3): 839 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Harlap, O. Paltiel, Y. Friedlander, R. Calderon-Margalit, L. Deutsch, K. R. Kleinhaus, O. Manor, A. I. Neugut, M. Opler, M. C. Perrin, et al. Prostate Cancer in Fathers With Fewer Male Offspring: the Jerusalem Perinatal Study Cohort J Natl Cancer Inst, January 3, 2007; 99(1): 77 - 81. [Abstract] [Full Text] [PDF]
|
|